Abstract
The purpose of the present study was to compare the impact of pulmonary function, body habitus, and stereotactic body radiation therapy (SBRT) immobilization on setup and reproducibility for upper lung tumor. From 2008 through 2011, our institution's prospective SBRT database was searched for patients with upper lung tumors. Two SBRT immobilization strategies were used: full‐length BodyFIX and thermoplastic S‐frame. At simulation, free‐breathing, four‐dimensional computed tomography was performed. For each treatment, patients were set up to isocenter with in‐room lasers and skin tattoos. Shifts from initial and subsequent couch positions with cone‐beam computed tomography (CBCT) were analyzed. Accounting for setup uncertainties, institutional tolerance of CBCT‐based shifts for treatment was 2, 2, and 4 mm in left–right, anterior–posterior, and cranial–caudal directions, respectively; shifts exceeding these limits required reimaging. Each patient's pretreatment pulmonary function test was recorded. A multistep, multivariate linear regression model was performed to elucidate intervariable dependency for three‐dimensional calculated couch shift parameters. BodyFIX was applied to 76 tumors and S‐frame to 17 tumors. Of these tumors, 41 were non–small cell lung cancer and 15 were metastatic from other sites. Lesions measured , 1.1 to 2 (50%), 2.1 to 3 (25%), and cm. Errors from first shifts of first fractions were significantly less with S‐frame than BodyFIX (). No difference in local control (LC) was found between S‐frame and BodyFIX (); two‐year LC rate was 94%. Multivariate modeling confirmed that the ratio of forced expiratory volume in the first second of expiration to forced vital capacity, body habitus, and the immobilization device significantly impacted couch shift errors. For upper lung tumors, initial setup was more consistent with S‐frame than BodyFIX, resulting in fewer CBCT scans. Patients with obese habitus and poor lung function had more SBRT setup uncertainty; however, outcome and probability for LC remained excellent.
PACS number: 89.20.‐a
Keywords: body mass index, immobilization, pulmonary function test, stereotactic body radiation therapy, upper lung tumors
Supporting information
References
- 1. Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Ricardi U, Filippi AR, Guarneri A et al. Stereotactic body radiation therapy for lung metastases. Lung Cancer. 2012;75(1):77–81. [DOI] [PubMed] [Google Scholar]
- 3. Fritz P, Kraus HJ, Muhlnickel W et al. Stereotactic, single‐dose irradiation of stage I non‐small cell lung cancer and lung metastases. Radiat Oncol. 2006;1:30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186–96. [DOI] [PubMed] [Google Scholar]
- 5. Stephans K. Stereotactic body radiotherapy for stage I non‐small cell lung cancer. Cleve Clin J Med. 2012;79 Electronic Suppl 1:eS26–e531. [DOI] [PubMed] [Google Scholar]
- 6. Bennouna J, Breton JL, Tourani JM et al. Vinflunine: an active chemotherapy for treatment of advanced non‐small‐cell lung cancer previously treated with a platinum‐based regimen: results of a phase II study. Br J Cancer. 2006;94(10):1383–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Han K, Cheung P, Basran PS, Poon I, Yeung L, Lochray F. A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors. Radiother Oncol. 2010;95(1):103–08. [DOI] [PubMed] [Google Scholar]
- 8. Stauder MC, Macdonald OK, Olivier KR et al. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011;99(2):166–71. [DOI] [PubMed] [Google Scholar]
- 9. Nagata Y, Takayama K, Matsuo Y et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427–31. [DOI] [PubMed] [Google Scholar]
- 10. Baba F, Shibamoto Y, Tomita N et al. Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results. Radiat Oncol. 2009;4:15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Sonke JJ, Rossi M, Wolthaus J, van Herk M, Damen E, Belderbos J. Frameless stereotactic body radiotherapy for lung cancer using four‐dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys. 2009;74(2):567–74. [DOI] [PubMed] [Google Scholar]
- 12. Yeung AR, Li JG, Shi W et al. Tumor localization using cone‐beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2009;74(4):1100–07. [DOI] [PubMed] [Google Scholar]
- 13. Negoro Y, Nagata Y, Aoki T et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys. 2001;50(4):889–98. [DOI] [PubMed] [Google Scholar]
- 14. Matsugi K, Narita Y, Sawada A et al. Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2009;75(2):543–48. [DOI] [PubMed] [Google Scholar]
- 15. Purdie TG, Bissonnette JP, Franks K et al. Cone‐beam computed tomography for on‐line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys. 2007;68(1):243–52. [DOI] [PubMed] [Google Scholar]
- 16. Stevens CW, Munden RF, Forster KM et al. Respiratory‐driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys. 2001;51(1):62–68. [DOI] [PubMed] [Google Scholar]
- 17. Mazzone P. Preoperative evaluation of the lung resection candidate. Cleve Clin J Med. 2012;79 Electronic Suppl 1:eS17–e522. [DOI] [PubMed] [Google Scholar]
- 18. Stephans KL, Djemil T, Reddy CA et al. Comprehensive analysis of Pulmonary Function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol. 2009;4(7):838–44. [DOI] [PubMed] [Google Scholar]
- 19. Takeda A, Enomoto T, Sanuki N et al. Reassessment of declines in pulmonary function ≥ 1 year after stereotactic body radiotherapy. Chest. 2013;143(1):130–37. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.